TY  - GEN
AU  - Glander,Petra
AU  - Waiser,Johannes
AU  - Kasbohm,Silke
AU  - Friedersdorff,Frank
AU  - Peters,Robert
AU  - Rudolph,Birgit
AU  - Wu,Kaiyin
AU  - Budde,Klemens
AU  - Liefeldt,Lutz
TI  - Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation
SN  - 1399-0012
PY  - 2019///1108
KW  - Biological Availability
KW  - Cost-Benefit Analysis
KW  - Delayed-Action Preparations
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Glomerular Filtration Rate
KW  - Graft Rejection
KW  - drug therapy
KW  - Graft Survival
KW  - Humans
KW  - Immunosuppressive Agents
KW  - economics
KW  - Kidney Failure, Chronic
KW  - Kidney Function Tests
KW  - Kidney Transplantation
KW  - adverse effects
KW  - Male
KW  - Middle Aged
KW  - Multicenter Studies as Topic
KW  - Prognosis
KW  - Prospective Studies
KW  - Randomized Controlled Trials as Topic
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Tacrolimus
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1111/ctr.13311
ER  -